{
    "url_original": "https://www.wsj.com/articles/new-covid-19-pills-carry-risks-what-patients-should-know-11641033002?mod=business_lead_pos11",
    "url": "new-covid-19-pills-carry-risks-what-patients-should-know-11641033002",
    "title": "New Covid-19 Pills Carry Risks: What Patients Should Know",
    "sub_head": "Pfizer’s antiviral treatment can interact with other drugs, and Merck’s isn’t recommended for pregnant women",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2022-01-01 05:30:00",
    "body": "The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but they carry safety warnings and limitations that could complicate treatment decisions for patients, doctors and pharmacists.<br />In December, the Food and Drug Administration authorized the use of new pills from  Merck  & Co., with its partner Ridgeback Biotherapeutics, and  Pfizer Inc.,  for the treatment of mild to moderate Covid-19 in people at high risk of worsening to severe disease, such as the elderly or those with certain chronic medical conditions."
}